Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 3 Reasons Pfizer, Inc. Investors Shouldn't Be Concerned About the Q1 Revenue Dip
3 Reasons Pfizer, Inc. Investors Shouldn't Be Concerned About the Q1 Revenue Dip
3 Reasons Pfizer, Inc. Investors Shouldn't Be Concerned About the Q1 Revenue Dip
Submitted by
admin
on May 3, 2017 - 10:08am
Source:
Motley Fool
News Tags:
Pfizer
earnings
Headline:
3 Reasons Pfizer, Inc. Investors Shouldn't Be Concerned About the Q1 Revenue Dip
Do Not Allow Advertisers to Use My Personal information
